Garth Parham, Ph.D.

Business Development Manager at Actinium Pharmaceuticals, Inc.
  • Claim this Profile
Contact Information
Location
Indianapolis, Indiana, United States, IN
Languages
  • English Native or bilingual proficiency

Topline Score

Bio

Generated by
Topline AI

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.
You need to have a working account to view this content. Click here to join now

Experience

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Business Development Manager
      • Jun 2023 - Present

    • Senior Associate
      • Oct 2022 - Jun 2023

    • China
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Business Development Manager
      • Oct 2021 - Aug 2022
    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Principal Scientist II
      • Dec 2018 - Sep 2021
    • United States
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Senior Research Scientist
      • Feb 2013 - Dec 2018

      Develops products for targeted radioligand therapy and precision radioligand imaging; acquired by Novartis in 2017. Recruited amidst aggressive corporate expansion during company's 1st pharmaceutical approval and commercialization for the European market while simultaneously developing 2 promising drug candidates in the pipeline; the 1st Chemist hired in 7 years. Conduct various early stage Structure Activity Relationship (SAR) research studies on receptor radioligands, imaging… Show more Develops products for targeted radioligand therapy and precision radioligand imaging; acquired by Novartis in 2017. Recruited amidst aggressive corporate expansion during company's 1st pharmaceutical approval and commercialization for the European market while simultaneously developing 2 promising drug candidates in the pipeline; the 1st Chemist hired in 7 years. Conduct various early stage Structure Activity Relationship (SAR) research studies on receptor radioligands, imaging agents and small molecule drug conjugates for targeted anti-tumor therapy discovery. Provide strategic, technical and scientific leadership to team of Research Scientists, Associate Chemists and Chemistry Director in drug discovery programs; supervise and mentor chemistry interns. Key participant in R&D meetings, working with the C-suite to resolve issues, establish goals/objectives, advise on capital equipment acquisitions and improve project planning, processes and techniques. Source, negotiate and manage CRO relationships and vendor alliances. Collaborate cross-functionally to attain corporate goals; coordinate projects with the Discovery Biology group and partner with Chemistry, Manufacturing and Controls (CMC) team on technology transfers and protocol development. Actively support patent drafting and filing as well as development of academic papers. Earned Endostar Management and Peer-to-Peer Awards; completed comprehensive Management Training Program. Promoted from Synthetic Organic Chemist II position within 18 months for project leadership and ability to meet deliverables within expedited timelines. Show less Develops products for targeted radioligand therapy and precision radioligand imaging; acquired by Novartis in 2017. Recruited amidst aggressive corporate expansion during company's 1st pharmaceutical approval and commercialization for the European market while simultaneously developing 2 promising drug candidates in the pipeline; the 1st Chemist hired in 7 years. Conduct various early stage Structure Activity Relationship (SAR) research studies on receptor radioligands, imaging… Show more Develops products for targeted radioligand therapy and precision radioligand imaging; acquired by Novartis in 2017. Recruited amidst aggressive corporate expansion during company's 1st pharmaceutical approval and commercialization for the European market while simultaneously developing 2 promising drug candidates in the pipeline; the 1st Chemist hired in 7 years. Conduct various early stage Structure Activity Relationship (SAR) research studies on receptor radioligands, imaging agents and small molecule drug conjugates for targeted anti-tumor therapy discovery. Provide strategic, technical and scientific leadership to team of Research Scientists, Associate Chemists and Chemistry Director in drug discovery programs; supervise and mentor chemistry interns. Key participant in R&D meetings, working with the C-suite to resolve issues, establish goals/objectives, advise on capital equipment acquisitions and improve project planning, processes and techniques. Source, negotiate and manage CRO relationships and vendor alliances. Collaborate cross-functionally to attain corporate goals; coordinate projects with the Discovery Biology group and partner with Chemistry, Manufacturing and Controls (CMC) team on technology transfers and protocol development. Actively support patent drafting and filing as well as development of academic papers. Earned Endostar Management and Peer-to-Peer Awards; completed comprehensive Management Training Program. Promoted from Synthetic Organic Chemist II position within 18 months for project leadership and ability to meet deliverables within expedited timelines. Show less

    • United States
    • Higher Education
    • 700 & Above Employee
    • Graduate Research Assistant
      • 2006 - 2012

      Top-ranking public research institution. Earned valuable training in substrate- and enzyme-bound interactions; synthesis and development of stereospecific heterocyclic ring structures; metal catalyzed cycloaddition reactions (Mn, Ag, Rh mediated); enzyme catalyzed acetalization reactions of enantiomers; and derivatization of compounds for x-ray crystallization studies. Utilized YASARA molecular graphics, modeling and simulation software for SAR studies. Secured Alliance… Show more Top-ranking public research institution. Earned valuable training in substrate- and enzyme-bound interactions; synthesis and development of stereospecific heterocyclic ring structures; metal catalyzed cycloaddition reactions (Mn, Ag, Rh mediated); enzyme catalyzed acetalization reactions of enantiomers; and derivatization of compounds for x-ray crystallization studies. Utilized YASARA molecular graphics, modeling and simulation software for SAR studies. Secured Alliance from Graduate Education and the Professoriate Faculty Grant (AGEP) research funding. Tutored and mentored undergraduate chemistry and general studies students. Show less Top-ranking public research institution. Earned valuable training in substrate- and enzyme-bound interactions; synthesis and development of stereospecific heterocyclic ring structures; metal catalyzed cycloaddition reactions (Mn, Ag, Rh mediated); enzyme catalyzed acetalization reactions of enantiomers; and derivatization of compounds for x-ray crystallization studies. Utilized YASARA molecular graphics, modeling and simulation software for SAR studies. Secured Alliance… Show more Top-ranking public research institution. Earned valuable training in substrate- and enzyme-bound interactions; synthesis and development of stereospecific heterocyclic ring structures; metal catalyzed cycloaddition reactions (Mn, Ag, Rh mediated); enzyme catalyzed acetalization reactions of enantiomers; and derivatization of compounds for x-ray crystallization studies. Utilized YASARA molecular graphics, modeling and simulation software for SAR studies. Secured Alliance from Graduate Education and the Professoriate Faculty Grant (AGEP) research funding. Tutored and mentored undergraduate chemistry and general studies students. Show less

    • United States
    • Environmental Services
    • Chemist
      • 2006 - 2006

      Environmental testing company; sold to HIG Capital in 2007. Gained exposure to industrial chemistry applications within a CRO setting. Performed liter scale isolations, identifying, tracking and quantifying environmentally harmful compounds (primarily pesticides and herbicides) in water and soil samples. Environmental testing company; sold to HIG Capital in 2007. Gained exposure to industrial chemistry applications within a CRO setting. Performed liter scale isolations, identifying, tracking and quantifying environmentally harmful compounds (primarily pesticides and herbicides) in water and soil samples.

    • United States
    • Higher Education
    • 400 - 500 Employee
    • Undergraduate Research Assistant
      • 2003 - 2005

      Initiated research into a model for analyzing soot aerosol reactivity with atmospheric gases. Assisted with new lab set up; procured and constructed instrumentation for future undergrad researchers. Initiated research into a model for analyzing soot aerosol reactivity with atmospheric gases. Assisted with new lab set up; procured and constructed instrumentation for future undergrad researchers.

Education

  • Purdue University
    Doctor of Philosophy (Ph.D.), Organic Chemistry
  • Arizona State University - W. P. Carey School of Business
    Master of Business Administration - MBA, 3.88/4.0
  • Viterbo University
    Bachelor of Science - BS, Chemistry
  • Toulouse Business School - Barcelona
    Study Abroad Program, International Business in Europe

Community

You need to have a working account to view this content. Click here to join now